Site icon pharmaceutical daily

2-Day Veterinary Drug Approval Process and FDA Regulatory Oversight Virtual Seminar, August 17-18, 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Veterinary Drug Approval Process and FDA Regulatory Oversight” conference has been added to ResearchAndMarkets.com’s offering.

This two-day interactive seminar online will provide attendees with an understanding of FDA’s veterinary drug approval process in 2021. The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species.

This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies.

For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.

The group size is small, generally between 8 and 10 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.

Learning Objectives:

Key goals of the seminar will include learning:

Time: 12:00 PM – 05:00 PM EDT

Who Should Attend:

This course is designed primarily for people tasked with developing new animal drugs for an animal health company or a human pharmaceutical company. This includes individuals responsible for overseeing regulatory affairs, developing veterinary drug products, or evaluating new technologies or applications. Among others, this includes:

Agenda:

DAY 01 (12:00 PM – 05:00 PM EDT)

Introduction to the Veterinary Drug Approval Process

Developing the NADA Technical Sections

DAY 02 (12:00 PM – 05:00 PM EDT)

Developing the NADA Technical Sections (continued)

Overview of Generic Animal Drugs (JINAD)

Minor Use Minor Species (MUMS)

Marketing Exclusivity & Exclusive Marketing Rights

Animal Drug User Fees and related waivers

Animal Feed, OTC Drugs, Supplements, Medical Devices

USDA & EPA

Non-Approval-Related Considerations

For more information about this conference visit https://www.researchandmarkets.com/r/ly9sgv

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Exit mobile version